People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

8:46pm IST
Change (% chg)

$0.12 (+4.26%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Terreri, Peter 

Mr. Peter R. Terreri CPA. is a Independent Director of Impax Laboratories Inc. has served on our Board of Directors since the Combination, and previously as a member of the board of directors of Impax from 2003 until the completion of the Combination. Mr. Terreri is currently President, Chief Executive Officer and director of CGM, Inc., a manufacturing company that he has owned and operated since 2000. He previously served as Senior Vice President and Chief Financial Officer of Teva Pharmaceuticals USA, Inc. from 1985 through 2000 and as an auditor at PricewaterhouseCoopers LLP from 1981 to 1984. Mr. Terreri received his BS in Accounting from Drexel University and has been a certified public accountant since 1981. Mr. Terreri’s more than 20 years of experience in the pharmaceutical industry provides the Board with comprehensive understanding of our operations and strategy. His prior experience as Chief Financial Officer of a major generic pharmaceutical company also brings to the Board deep understanding of accounting and risk management issues.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 91,667
Long-Term Incentive Plans, USD --
All Other, USD 255,000
Fiscal Year Total, USD 346,667

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --